Byeong‐Keuk Kim

ORCID: 0000-0003-2493-066X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Coronary Interventions and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Lipoproteins and Cardiovascular Health
  • Peripheral Artery Disease Management
  • Cardiac Valve Diseases and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Aortic aneurysm repair treatments
  • Atrial Fibrillation Management and Outcomes
  • Vascular Procedures and Complications
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pharmaceutical Economics and Policy
  • Cardiovascular Function and Risk Factors
  • Health Systems, Economic Evaluations, Quality of Life
  • Optical Coherence Tomography Applications
  • Blood Pressure and Hypertension Studies
  • Mechanical Circulatory Support Devices
  • Cancer, Lipids, and Metabolism
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Treatment and Management
  • Cardiac Arrest and Resuscitation
  • Acute Kidney Injury Research
  • Cardiovascular Health and Disease Prevention

Yonsei University
2016-2025

Gangnam Severance Hospital
2016-2025

Severance Hospital
2016-2025

Sungkyunkwan University
2015-2025

Kangbuk Samsung Hospital
2025

Yonsei University Health System
2015-2024

University Health System
2011-2024

Science Health Allied Research Education
2024

Singapore-HUJ Alliance for Research and Enterprise
2024

SHARE
2024

Use of intravascular ultrasound (IVUS) promotes better clinical outcomes for coronary intervention in complex lesions. However, randomized data demonstrating the usefulness IVUS are limited lesions treated with drug-eluting stents.To determine whether long-term IVUS-guided stent implantation superior to those angiography-guided patients long lesions.The Impact Intravascular Ultrasound Guidance on Outcomes Xience Prime Stents Long Lesions (IVUS-XPL) randomized, multicenter trial was conducted...

10.1001/jama.2015.15454 article EN JAMA 2015-11-10

<h3>Importance</h3> Discontinuing aspirin after short-term dual antiplatelet therapy (DAPT) was evaluated as a bleeding reduction strategy. However, the strategy of ticagrelor monotherapy has not been exclusively in patients with acute coronary syndromes (ACS). <h3>Objective</h3> To determine whether switching to 3 months DAPT reduces net adverse clinical events compared ticagrelor-based 12-month ACS treated drug-eluting stents. <h3>Design, Setting, and Participants</h3> A randomized...

10.1001/jama.2020.7580 article EN JAMA 2020-06-16

There have been no randomized studies comparing intravascular ultrasound (IVUS)-guided versus conventional angiography-guided chronic total occlusion (CTO) intervention using new-generation drug-eluting stent Therefore, we conducted a prospective, randomized, multicenter trial designed to test the hypothesis that IVUS-guided CTO is superior intervention.After successful guidewire crossing, 402 patients with CTOs were group (n=201) or and secondarily Resolute zotarolimus-eluting stents Nobori...

10.1161/circinterventions.115.002592 article EN Circulation Cardiovascular Interventions 2015-07-01

BACKGROUND: Stopping aspirin within 1 month after implantation of a drug-eluting stent for ticagrelor monotherapy has not been exclusively evaluated patients with acute coronary syndrome. The aim this study was to investigate whether &lt;1 dual antiplatelet therapy (DAPT) is noninferior 12 months ticagrelor-based DAPT adverse cardiovascular and bleeding events in METHODS: In randomized, open-label, noninferiority trial, 2850 syndrome who underwent at 24 centers South Korea were randomly...

10.1161/circulationaha.123.066943 article EN Circulation 2023-10-25

In patients with coronary artery disease, some guidelines recommend initial statin treatment high-intensity statins to achieve at least a 50% reduction in low-density lipoprotein cholesterol (LDL-C). An alternative approach is begin moderate-intensity and titrate specific LDL-C goal. These alternatives have not been compared head-to-head clinical trial involving known disease.To assess whether treat-to-target strategy noninferior of for long-term outcomes disease.A randomized, multicenter,...

10.1001/jama.2023.2487 article EN JAMA 2023-03-06

Abstract Background and Aims Drug-coated balloons (DCBs) have demonstrated favourable outcomes following endovascular therapy for femoropopliteal artery (FPA) disease. However, uncertainty remains whether the use of intravascular ultrasound (IVUS) can improve DCBs. Methods This prospective, multicentre, randomized trial, conducted at seven centres in South Korea, compared IVUS-guided vs. angiography-guided angioplasty treating FPA disease with Patients were assigned to receive (n = 119) or...

10.1093/eurheartj/ehae372 article EN European Heart Journal 2024-07-05

<h3>Objective</h3> To investigate the long-term prognostic implications of contrast-induced acute kidney injury (CI-AKI) with transient or persistent renal dysfunction in myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI). <h3>Design</h3> A retrospective observational registry study. <h3>Setting</h3> Clinical follow-up after PCI. <h3>Patients and methods</h3> total 1041 PCI-treated AMI from Infarction Prognosis Study registry. CI-AKI was defined as an...

10.1136/hrt.2010.218677 article EN Heart 2011-05-20

Background— We investigated the incidences, predictors, and clinical outcomes of acute late stent malapposition detected by optical coherence tomography (OCT) after drug-eluting implantation. Methods Results— analyzed OCT images from 351 patients with 356 lesions who received poststent follow-up examinations. Acute was observed in 62% lesions. Approximately half malappositions were located within edges stents. Severe diameter stenosis, calcified lesions, long stents independent predictors...

10.1161/circinterventions.113.000797 article EN Circulation Cardiovascular Interventions 2014-01-15
Coming Soon ...